DHL Group has announced a strategic investment of €2 billion over the next five years to enhance its logistics operations in the Life Sciences & Healthcare (LSH) sector. The initiative is part of the Group’s “Strategy 2030” and aims to build
DHL Group has expanded its life sciences and healthcare logistics business with the acquisition of CRYOPDP, a specialized courier service provider handling over 600,000 shipments annually across 135 countries. The acquisition aligns with DHL’s Strategy 2030, reinforcing its capabilities in temperature-controlled networks
Körber has partnered with Amazon Web Services (AWS) to provide fully managed, cloud-based manufacturing execution system (MES) solutions for the life sciences sector. The move aligns with industry trends, as pharmaceutical manufacturers increasingly seek flexible, scalable, and cost-effective digital solutions to improve supply
Frontier Scientific Solutions is leveraging its Free Trade Zone (FTZ) at Wilmington International Airport (ILM) to help life sciences companies mitigate supply chain disruptions and cost increases as new U.S. trade tariffs take effect. The FTZ designation offers tariff deferrals, exemptions,
Bio X Cell, a provider of functional antibodies for translational research, is expanding its international footprint with a new distribution center in Beijing, China, set to open in March 2025. This marks a strategic move to enhance service for researchers
Frontier Scientific Solutions has announced the ongoing construction of its state-of-the-art cGMP temperature-controlled facility at Wilmington International Airport (ILM). The site will be the largest of its kind in North America dedicated solely to the life sciences sector, reinforcing Wilmington’s
Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer centre, has announced a strategic partnership with Cryoport, Inc., a global leader in supply chain solutions for the life sciences sector. The collaboration will see Cryoport’s CRYOGENE business unit provide
Eckert & Ziegler has signed a global supply agreement with GlyTherix Ltd to provide Actinium-225 (Ac-225) in support of the latter’s clinical research and development of targeted radiotherapy. This collaboration extends the companies’ existing partnership, which is focused on Lutetium-177-based
ITM Isotope Technologies Munich SE (ITM) has announced a supply agreement with Ariceum Therapeutics to deliver non-carrier-added (n.c.a.) Actinium-225 (Ac-225) for use in the development of Ariceum’s novel radiopharmaceutical therapies. The agreement is set to support Ariceum’s pipeline, which includes
GenScript Biotech Corporation has become a Supplier Partner of the Pharmaceutical Supply Chain Initiative (PSCI), a global association dedicated to promoting responsible practices in the pharmaceutical industry. This milestone is part of GenScript’s ongoing efforts to integrate sustainability and ethics
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
